TMCnet News
Clinigen Group plc: Full Year ResultsClinigen Group plc (AIM: CLIN, 'Clinigen' or 'the Group'), the global pharmaceuticals and services group, has today published its full year results for the year ended 30 June 2017. FINANCIAL SUMMARY
Note: The Group results on an adjusted basis exclude amortisation and non-underlying costs (see note 2 and 3 of this financial information). Adjusted EBITDA is also adjusted to include the Group's share of EBITDA from its joint venture. Adjusted EBITDA and adjusted EPS metrics are now shown after share-based payments of £2.5m (2016: £2.3m). Prior year has been restated accordingly. HIGHLIGHTS
POST PERIOD END
Shaun Chilton, Group Chief Executive Officer, said: "All of our business operations have performed strongly over the year resulting in a 25% increase in adjusted EPS and a 25% increase in dividend. "We have continued to make significant progress in our strategy to build scale and capability in high growth geographies in the Africa and Asia Pacific region. "Our strategic priorities remain unchanged - we continue to drive organic growth across all parts of the Group and search for selective acquisitions to complement our existing offering and capabilities. "In line with this strategy, our recently announced proposed acquisition of Quantum would extend our Unlicensed Medicines capability, accelerate Clinigen's unlicensed to licensed global strategy and enable Clinigen to internationalise Quantum's existing portfolio of commercial products. "The Group is well positioned to deliver another good year of progress and longer term the Board believes we are in an excellent position to capitalise on the substantial opportunity in our markets." *Adjusted results exclude amortisation and non-underlying costs. Adjusted EBITDA includes the 50% share of the EBITDA from the joint venture in South Africa. Adjusted results are now shown after share-based payments and the prior year has been restated accordingly. The full release and a video of the CEO and CFO describing today's results can be seen here: http://www.clinigengroup.com/results-reports-presentations
View source version on businesswire.com: http://www.businesswire.com/news/home/20170927006502/en/ |